Muri, Switzerland

Sabine Zollner

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 3.5

ph-index = 3

Forward Citations = 16(Granted Patents)


Location History:

  • Muri, CH (2016 - 2021)
  • Guemligen, CH (2022)

Company Filing History:


Years Active: 2016-2022

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: **The Innovative Contributions of Sabine Zollner**

Introduction

Sabine Zollner, an accomplished inventor based in Muri, Switzerland, has made significant advancements in the field of biotechnology. With a total of nine patents to her name, her work focuses primarily on improving the stability and bioavailability of therapeutic proteins, particularly Factor VIII, which is crucial for treating hemophilia.

Latest Patents

Among her most notable contributions are her recent patents related to the "Method for improving the stability of purified Factor VIII after reconstitution." This innovation outlines a method aimed at enhancing the stability of the Factor VIII molecule post-purification, lyophilization, and reconstitution. The process involves preventing proteolytic cleavage of the Factor VIII molecule into fragments that include essential domains, thereby maintaining its integrity throughout manufacturing. Additionally, her disclosures emphasize methods to improve the bioavailability of Factor VIII following both intravenous and non-intravenous injections, highlighting her commitment to advancing treatment efficacy for patients.

Career Highlights

Sabine Zollner has built her career by working with leading companies in the biotechnology industry, such as CSL Limited and CSL Behring GmbH. Her role in these organizations has enabled her to apply her innovative ideas to real-world applications, making a substantial impact on healthcare and patient outcomes.

Collaborations

Throughout her career, Zollner has collaborated with talented professionals including Hubert Metzner and Stefan Schulte. These partnerships have fostered an environment of innovation and creativity, further enhancing her contributions to the field.

Conclusion

Sabine Zollner's work exemplifies the spirit of innovation in biotechnology. Her nine patents reflect her dedication to improving therapeutic methods, specifically for sensitive treatments such as Factor VIII. As she continues to push the boundaries of medical science, her contributions will undoubtedly remain influential in shaping the future of biotechnology and patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…